Presenter: Prof. Jong Seung Kim, Member of Korea Academy of Science &Technology
Department of Chemistry (College of Science), Korea University
Title: Antitumor Theranostics and Its Delivery Sensing
Time: 4:00 PM, Aug 29
Location: 909B
Abstract
The advances in genomics, proteomics, and bioinformatics have directed the development of new anticancer agents to reduce drug abuse and increase safe and specific drug treatment. Theranostics, combining therapy and diagnosis, is an appealing approach for chemotherapy in medicine which exhibit improved biodistribution, selective cancer targeting ability, reduced toxicity, masked drug efficacy, and minimum side effects. The role of diagnosis tool in theranostic is to collect the information of diseased state before and after specific treatment. Magnetic particle-, mesoporous silica-, various carbon allotrope-, and polymer nanoparticle-based theranostic systems are well accepted and clinically significant. Currently, small conjugate-based systems have received much attention for cancer treatment and diagnosis. The structural architecture of these systems is relatively simple, compact, biocompatible, and unidirectional. In this talk, the latest developments on small conjugate based theranostic agents for tumor treatment and diagnosis using fluorescence undertaken in my lab will be given.
Biography
Jong Seung Kim was born in Daejon, Korea in 1963. He received Ph.D. from Department of Chemistry and Biochemistry at Texas Tech University. After one-year postdoctoral fellowship at University of Houston, he joined the faculty at Konyang University in 1994 and transferred to Dankook University in 2003. In 2007, he then moved to the Department of Chemistry at Korea University in Seoul as a professor. To date, his research records 355 scientific publications (citation = 16700, H index = 68) and 50 domestic and international patents. He became the Member of Korea Academy of Science and Technology in 2014.
Contact: Prof. Zhuang Liu
（责任编辑：张伶 邮箱：462696345@qq.com）